Margareta Elisabeth Björk
Director/Board Member bei PHARVARIS N.V.
Vermögen: 510 592 $ am 31.03.2024
Profil
Dr. Margareta Elisabeth Björk is an Independent Non-Executive Director at Calliditas Therapeutics AB, an Independent Non-Executive Director at Pharvaris NV, an Independent Director at Rocket Pharmaceuticals, Inc., a Senior VP & Head-Late-stage Development at AstraZeneca PLC and an Associate Professor at University of Uppsala.
She is on the Board of Directors at Vicore Pharma Holding AB, Calliditas Therapeutics AB, Pharvaris NV, Rocket Pharmaceuticals, Inc., Björks Matematik o Mera AB, Chalmers University of Technology and Rfidcompare Europe AB.
Dr. Björk was previously employed as a Head-Diabetes & Endocrinology Unit by Uppsala University Hospital.
She also served on the board at Albireo Ltd.
She received her doctorate degree from Karolinska Institutet and a doctorate degree from the University of Uppsala.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PHARVARIS N.V.
0,04% | 01.04.2024 | 22 094 ( 0,04% ) | 510 592 $ | 31.03.2024 |
22.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Margareta Elisabeth Björk
Unternehmen | Position | Beginn |
---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 01.06.2012 |
ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 20.04.2020 |
PHARVARIS N.V. | Director/Board Member | 01.12.2021 |
CALLIDITAS THERAPEUTICS AB | Director/Board Member | 01.01.2022 |
VICORE PHARMA HOLDING AB | Director/Board Member | 01.01.2023 |
University of Uppsala | Corporate Officer/Principal | - |
Chalmers University of Technology | Director/Board Member | - |
Björks Matematik o Mera AB | Director/Board Member | - |
Rfidcompare Europe AB | Director/Board Member | - |
Ehemalige bekannte Positionen von Margareta Elisabeth Björk
Unternehmen | Position | Ende |
---|---|---|
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Margareta Elisabeth Björk
Karolinska Institutet | Doctorate Degree |
University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
ASTRAZENECA PLC | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
VICORE PHARMA HOLDING AB | Health Technology |
PHARVARIS N.V. | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
Björks Matematik o Mera AB | |
Rfidcompare Europe AB |